He has held roles of increasing complexity and responsibility in the pharmaceutical industry for more than 20 years, across multiple business units and functional areas in europe, the united states and japan. Curevac has had approximately 375 employees since may 2018 Alexander zehnder, m.d, mba, is chief executive officer at curevac n.v Since april 01, 2023 and is its managing director since march 2023 and serves as its member of management board since 2023. Alexander zehnder, md, mba, currently serves as the chief executive officer of curevac since april 2023. Cvac) is a global biopharmaceutical company in the field of messenger rna (mrna) technology, with more than 20 years of expertise in developing, optimizing, and manufacturing.
Curevac's key executives include ingmar hoerr and 4 others. Cvac) is a global biopharmaceutical company in the field of messenger rna (mrna) technology, with more than 20 years of expertise in developing, optimizing, and manufacturing this versatile biological molecule for medical purposes. After 25 years of trying to lead biopharma's mrna revolution across infectious diseases and cancer, german biotech curevac made the surprise announcement that it would exit to its rival biontech, even as litigation continues over its patented technology.
OPEN
